NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|544346322|ref|NP_001269683|]
View 

phosphate-regulating neutral endopeptidase PHEX isoform 2 [Homo sapiens]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
Gene Ontology:  GO:0008270|GO:0008237
MEROPS:  M13
PubMed:  18215274|7674922
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
74-695 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 666.76  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  74 VDPCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKAKILYSSCMNEKAIEKADA 153
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 154 KPLLHILRHspfrwpvlesnIGPegvWSERKFSLLQTLATFRGQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVRE 233
Cdd:cd08662   81 KPLKPLLDK-----------IGG---LPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 234 DYLDnsTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIP-HENRTSEAMYNKMNISELSAMIPQF 312
Cdd:cd08662  147 YYLD--EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 313 DWLGYIKKVIDtrlyphlkDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRV 392
Cdd:cd08662  225 DWKAYLKALGP--------PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKA 296
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 393 IQGTTTLLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEkENEWMDAGTKRKAKEKARAV 472
Cdd:cd08662  297 LSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAM 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 473 LAKVGYPEFIMNDTHVNEDLKAIKFSEaDYFGNVLQTRKYLAQSDFFWLRKAVPKTEWFTNPTTVNAFYSASTNQIRFPA 552
Cdd:cd08662  376 KVKIGYPDKWRDYSALDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPA 454
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 553 GELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSTESEEKFKEKTKCMINQYSNYYWKKaGL 632
Cdd:cd08662  455 GILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GL 532
                        570       580       590       600       610       620
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 544346322 633 NVKGKRTLGENIADNGGLREAFRAYRKWINDRrqglEEPLLPGITFTNNQLFFLSYAHGqWCN 695
Cdd:cd08662  533 HVNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQV-WCS 590
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
74-695 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 666.76  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  74 VDPCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKAKILYSSCMNEKAIEKADA 153
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 154 KPLLHILRHspfrwpvlesnIGPegvWSERKFSLLQTLATFRGQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVRE 233
Cdd:cd08662   81 KPLKPLLDK-----------IGG---LPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 234 DYLDnsTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIP-HENRTSEAMYNKMNISELSAMIPQF 312
Cdd:cd08662  147 YYLD--EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 313 DWLGYIKKVIDtrlyphlkDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRV 392
Cdd:cd08662  225 DWKAYLKALGP--------PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKA 296
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 393 IQGTTTLLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEkENEWMDAGTKRKAKEKARAV 472
Cdd:cd08662  297 LSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAM 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 473 LAKVGYPEFIMNDTHVNEDLKAIKFSEaDYFGNVLQTRKYLAQSDFFWLRKAVPKTEWFTNPTTVNAFYSASTNQIRFPA 552
Cdd:cd08662  376 KVKIGYPDKWRDYSALDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPA 454
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 553 GELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSTESEEKFKEKTKCMINQYSNYYWKKaGL 632
Cdd:cd08662  455 GILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GL 532
                        570       580       590       600       610       620
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 544346322 633 NVKGKRTLGENIADNGGLREAFRAYRKWINDRrqglEEPLLPGITFTNNQLFFLSYAHGqWCN 695
Cdd:cd08662  533 HVNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQV-WCS 590
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
67-695 3.51e-168

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 497.75  E-value: 3.51e-168
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  67 LSKVNLSVDPCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKaKI--LYSSCMN 144
Cdd:COG3590   30 LANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAGSDEQ-KIgdLYASFMD 108
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 145 EKAIEKADAKPLLhilrhspfrwPVLE--SNIgpegvwsERKFSLLQTLATFRGQYSNSVFiRLYVSPDDKASNEHILKL 222
Cdd:COG3590  109 EAAIEALGLAPLK----------PDLAriDAI-------KDKADLAALLAALHRAGVGGLF-GFGVDADLKNSTRYIAYL 170
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 223 DQATLSLAVREDYLDNSTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMN 301
Cdd:COG3590  171 GQGGLGLPDRDYYLKDDEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRvELRDPEKTYNPMT 250
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 302 ISELSAMIPQFDWLGYIKKVidtrlyphlkDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRR 381
Cdd:COG3590  251 VAELAKLAPGFDWDAYLKAL----------GLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKA 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 382 FQYRWLEF-SRVIQGTTTLLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEKeNEWMDAG 460
Cdd:COG3590  321 FVDANFDFyGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIEN-LDWMSPE 399
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 461 TKRKAKEKARAVLAKVGYPEfimndthVNEDLKAIKFSEADYFGNVLQTRKylaqsdFFWLR------KAVPKTEWFTNP 534
Cdd:COG3590  400 TKAKALEKLAAFTPKIGYPD-------KWRDYSGLEIKRDDLVGNVLRASA------FEYQRelaklgKPVDRTEWGMTP 466
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 535 TTVNAFYSASTNQIRFPAGELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSTESEEKFKEK 614
Cdd:COG3590  467 QTVNAYYNPTMNEIVFPAAILQPPFF-DPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEAR 545
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 615 TKCMINQYSNYYWKKaGLNVKGKRTLGENIADNGGLREAFRAYRKwindRRQGLEEPLLPGitFTNNQLFFLSYAHGqWC 694
Cdd:COG3590  546 TKKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKL----SLKGKEAPVIDG--FTGDQRFFLGWAQV-WR 617

                 .
gi 544346322 695 N 695
Cdd:COG3590  618 S 618
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
76-479 8.17e-133

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 396.67  E-value: 8.17e-133
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322   76 PCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKAKILYSSCMNEKAIEKADAKP 155
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  156 LLHILRHspfrwpvlesnIGpEGVWSERKFSLLQTLATFRgQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVREDY 235
Cdd:pfam05649  81 LKPLLDE-----------IG-GPLANKDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYY 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  236 LDNSTEA-KSYRDALYKFMVDTAVLLGAnSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMNISELSAMIPQFD 313
Cdd:pfam05649 148 LKDRDEKsAEIREAYKAYIAKLLTLLGA-SEEAAALAEEVLAFETKLAKASLSReERRDPEKTYNPMTLAELQKLAPGID 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  314 WLGYIKKVidtrlyphLKDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRVI 393
Cdd:pfam05649 227 WKAYLNAA--------GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTL 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  394 QGTTTlLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEkENEWMDAGTKRKAKEKARAVL 473
Cdd:pfam05649 299 SGTKQ-RPRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLD-ELDWMDEETKKKALEKLDAMT 376

                  ....*.
gi 544346322  474 AKVGYP 479
Cdd:pfam05649 377 VKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
74-695 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 666.76  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  74 VDPCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKAKILYSSCMNEKAIEKADA 153
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 154 KPLLHILRHspfrwpvlesnIGPegvWSERKFSLLQTLATFRGQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVRE 233
Cdd:cd08662   81 KPLKPLLDK-----------IGG---LPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 234 DYLDnsTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIP-HENRTSEAMYNKMNISELSAMIPQF 312
Cdd:cd08662  147 YYLD--EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 313 DWLGYIKKVIDtrlyphlkDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRV 392
Cdd:cd08662  225 DWKAYLKALGP--------PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKA 296
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 393 IQGTTTLLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEkENEWMDAGTKRKAKEKARAV 472
Cdd:cd08662  297 LSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAM 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 473 LAKVGYPEFIMNDTHVNEDLKAIKFSEaDYFGNVLQTRKYLAQSDFFWLRKAVPKTEWFTNPTTVNAFYSASTNQIRFPA 552
Cdd:cd08662  376 KVKIGYPDKWRDYSALDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPA 454
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 553 GELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSTESEEKFKEKTKCMINQYSNYYWKKaGL 632
Cdd:cd08662  455 GILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GL 532
                        570       580       590       600       610       620
                 ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 544346322 633 NVKGKRTLGENIADNGGLREAFRAYRKWINDRrqglEEPLLPGITFTNNQLFFLSYAHGqWCN 695
Cdd:cd08662  533 HVNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQV-WCS 590
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
67-695 3.51e-168

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 497.75  E-value: 3.51e-168
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  67 LSKVNLSVDPCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKaKI--LYSSCMN 144
Cdd:COG3590   30 LANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAGSDEQ-KIgdLYASFMD 108
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 145 EKAIEKADAKPLLhilrhspfrwPVLE--SNIgpegvwsERKFSLLQTLATFRGQYSNSVFiRLYVSPDDKASNEHILKL 222
Cdd:COG3590  109 EAAIEALGLAPLK----------PDLAriDAI-------KDKADLAALLAALHRAGVGGLF-GFGVDADLKNSTRYIAYL 170
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 223 DQATLSLAVREDYLDNSTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMN 301
Cdd:COG3590  171 GQGGLGLPDRDYYLKDDEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRvELRDPEKTYNPMT 250
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 302 ISELSAMIPQFDWLGYIKKVidtrlyphlkDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRR 381
Cdd:COG3590  251 VAELAKLAPGFDWDAYLKAL----------GLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKA 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 382 FQYRWLEF-SRVIQGTTTLLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEKeNEWMDAG 460
Cdd:COG3590  321 FVDANFDFyGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIEN-LDWMSPE 399
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 461 TKRKAKEKARAVLAKVGYPEfimndthVNEDLKAIKFSEADYFGNVLQTRKylaqsdFFWLR------KAVPKTEWFTNP 534
Cdd:COG3590  400 TKAKALEKLAAFTPKIGYPD-------KWRDYSGLEIKRDDLVGNVLRASA------FEYQRelaklgKPVDRTEWGMTP 466
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 535 TTVNAFYSASTNQIRFPAGELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSTESEEKFKEK 614
Cdd:COG3590  467 QTVNAYYNPTMNEIVFPAAILQPPFF-DPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEAR 545
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322 615 TKCMINQYSNYYWKKaGLNVKGKRTLGENIADNGGLREAFRAYRKwindRRQGLEEPLLPGitFTNNQLFFLSYAHGqWC 694
Cdd:COG3590  546 TKKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKL----SLKGKEAPVIDG--FTGDQRFFLGWAQV-WR 617

                 .
gi 544346322 695 N 695
Cdd:COG3590  618 S 618
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
76-479 8.17e-133

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 396.67  E-value: 8.17e-133
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322   76 PCDNFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKELLEKSISRRRDTEAIQKAKILYSSCMNEKAIEKADAKP 155
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  156 LLHILRHspfrwpvlesnIGpEGVWSERKFSLLQTLATFRgQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVREDY 235
Cdd:pfam05649  81 LKPLLDE-----------IG-GPLANKDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYY 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  236 LDNSTEA-KSYRDALYKFMVDTAVLLGAnSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMNISELSAMIPQFD 313
Cdd:pfam05649 148 LKDRDEKsAEIREAYKAYIAKLLTLLGA-SEEAAALAEEVLAFETKLAKASLSReERRDPEKTYNPMTLAELQKLAPGID 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  314 WLGYIKKVidtrlyphLKDISPSENVVVRVPQYFKDLFRILGSERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRVI 393
Cdd:pfam05649 227 WKAYLNAA--------GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTL 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  394 QGTTTlLPQWDKCVNFIESALPYVVGKMFVDVYFQEDKKEMMEELVEGVRWAFIDMLEkENEWMDAGTKRKAKEKARAVL 473
Cdd:pfam05649 299 SGTKQ-RPRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLD-ELDWMDEETKKKALEKLDAMT 376

                  ....*.
gi 544346322  474 AKVGYP 479
Cdd:pfam05649 377 VKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
538-695 2.93e-55

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 187.62  E-value: 2.93e-55
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 544346322  538 NAFYSASTNQIRFPAGELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSTESEEKFKEKTKC 617
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFF-DPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQC 79
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 544346322  618 MINQYSNYYWKKAGLNVKGKRTLGENIADNGGLREAFRAYRKwindrRQGLEEPLLPGI-TFTNNQLFFLSYAHgQWCN 695
Cdd:pfam01431  80 LIEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKK-----LLSANETVLPGFeNLTPDQLFFRGAAQ-IWCM 152
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH